Search - tctmd.com

Displaying 21 - 36 of 36

Sort: Relevancy | Date

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Conference News EuroPCR 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Caitlin E. Cox

May 20, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Michael O'Riordan

March 04, 2024

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

News Daily News

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Michael O'Riordan

February 29, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

Advertisement

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

With ANOCA, Better to Test Coronary Function in Multiple Vessels

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content